Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Font

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
Revista Clinica Espanola|January 15, 1978
[Pulmonary thromboembolism in a medical clinic. Review of 104 cases]A Hurtado Fernández-Llamazares, J López Martínez, P Betancor León, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancersM Monzó, R Rosell, E Felip, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancerR Rosell, F Molina, I Moreno, et al.
Cancer|March 15, 1995
Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trialA Abad, P Garcia, C Gravalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 27, 2019
Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)M Lázaro, E Gallardo, M Doménech, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 4, 2007
Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancerA Font, A Arellano, J Fernández-Llamazares, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 6, 2024
Clinically important pharmacokinetic drug-drug interactions with antibacterial agentsA Torrent Rodríguez, A Font I Barceló, M Barrantes González, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumorsA Font, J M Sanchez, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
K-ras genotypes and prognosis in non-small-cell lung cancerR Rosell, M Monzo, F Molina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II studyE Felip, R Rosell, M Domine, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Revista Clinica Espanola|January 15, 1978
[Pulmonary thromboembolism in a medical clinic. Review of 104 cases]A Hurtado Fernández-Llamazares, J López Martínez, P Betancor León, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancersM Monzó, R Rosell, E Felip, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1995
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancerR Rosell, F Molina, I Moreno, et al.
Cancer|March 15, 1995
Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trialA Abad, P Garcia, C Gravalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 27, 2019
Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)M Lázaro, E Gallardo, M Doménech, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 4, 2007
Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancerA Font, A Arellano, J Fernández-Llamazares, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|June 6, 2024
Clinically important pharmacokinetic drug-drug interactions with antibacterial agentsA Torrent Rodríguez, A Font I Barceló, M Barrantes González, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumorsA Font, J M Sanchez, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
K-ras genotypes and prognosis in non-small-cell lung cancerR Rosell, M Monzo, F Molina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II studyE Felip, R Rosell, M Domine, et al.
Pageof 20